Skip to content
healthcare.dev

Lacosamide

NDC 0121-3036, Lacosamide, solution, from PAI Holdings, LLC dba PAI Pharma.

Product NDC
0121-3036
Status
Listed
Labeler
PAI Holdings, LLC dba PAI Pharma
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216151
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0121-3036 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE150 mg/15mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
0121-3036-95001213036951 TRAY in 1 CASE (0121-3036-95) / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (0121-3036-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/75de00d8-d2e7-4025-be4e-f49299068e7e

Use it

Look up 0121-3036 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0121-3036 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0121-3036. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.